Citations (70)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Hussein Ali Nwayyir, Esraa Majid Mutasher, Osama Mohammed Alabid, Muthana Abdulrazzaq Jabbar, Wefak Hasan Abdulraheem Al-Kawaz, Haider Ayad Alidrisi, Majid Alabbood, Muhammed Chabek, Munib AlZubaidi, Lujain Anwar Al-khazrajy, Ibtihal Shukri Abd Alhaleem, Ali Dawood Abdulwahhab Al-Hilfi, Falih Mohssen Ali, Ali AlBayati, Hilal Bahjet Al Saffar & Faris Abdul Kareem Khazaal. (2023) Recommendations for the prevention and management of obesity in the Iraqi population. Postgraduate Medicine 135:5, pages 425-439.
Read now
Read now
Luis Fernando Valladales-Restrepo, Nicolás Sánchez-Ramírez, Andrés Felipe Usma-Valencia, Andrés Gaviria-Mendoza, Manuel Enrique Machado-Duque & Jorge Enrique Machado-Alba. (2023) Effectiveness, persistence of use, and safety of orlistat and liraglutide in a group of patients with obesity. Expert Opinion on Pharmacotherapy 24:4, pages 535-543.
Read now
Read now
Win Min Oo, Ali Mobasheri & David J Hunter. (2022) A narrative review of anti-obesity medications for obese patients with osteoarthritis. Expert Opinion on Pharmacotherapy 23:12, pages 1381-1395.
Read now
Read now
Beverly G. Tchang, Mohamad Sirri Tarazi, Mohini Aras & Alpana P. Shukla. (2021) An update on pharmacotherapeutic strategies for obesity. Expert Opinion on Pharmacotherapy 22:10, pages 1305-1318.
Read now
Read now
Basak Ozgen Saydam & Bulent Okan Yildiz. (2021) Weight management strategies for patients with PCOS: current perspectives. Expert Review of Endocrinology & Metabolism 16:2, pages 49-62.
Read now
Read now
Laura Orsolini, Simone Pompili & Umberto Volpe. (2020) The ‘collateral side’ of mood stabilizers: safety and evidence-based strategies for managing side effects. Expert Opinion on Drug Safety 19:11, pages 1461-1495.
Read now
Read now
Articles from other publishers (64)
Areej Hazem Younes & Yasser Fakri Mustafa. (2023) Sweet Bell Pepper: A Focus on Its Nutritional Qualities and Illness-Alleviated Properties. Indian Journal of Clinical Biochemistry.
Crossref
Crossref
Mohamed M. Ashour, Mostafa Mabrouk, Mohamed A. Aboelnasr, Hanan H. Beherei, Khairy M. Tohamy & Diganta B. Das. (2023) Anti-Obesity Drug Delivery Systems: Recent Progress and Challenges. Pharmaceutics 15:11, pages 2635.
Crossref
Crossref
Kongming Fan, Yan Li, Qiaofeng Fu, Jinmin Wang, Yong Lin, Linyu Qiu, Li Ran, Junli Yang & Chunyan Yang. (2023) Bio-Assay-Guided Isolation of Fractions and Constituents with Antioxidant and Lipid-lowering Activity from Allium cepa. Antioxidants 12:7, pages 1448.
Crossref
Crossref
Mervin Chávez-Castillo, Pablo Duran, Bermary Garrido, Andrea Díaz, Daniel Escalona & Clímaco Cano. (2023) Obesity as a Neurobiologic Disorder: A Heavyweight Contender. Current Psychiatry Research and Reviews 19:2, pages 109-136.
Crossref
Crossref
Kenn Lee, Adeola Akinola & Seri Abraham. (2023) Antipsychotic-induced weight gain: exploring the role of psychiatrists in managing patients’ physical health – challenges, current options and direction for future care. BJPsych Bulletin, pages 1-6.
Crossref
Crossref
Jacob Levi, Junzheng Wang, Francois Venter & Andrew Hill. (2023) Estimated minimum prices and lowest available national prices for antiobesity medications: Improving affordability and access to treatment. Obesity 31:5, pages 1270-1279.
Crossref
Crossref
Laleh Pezhman, Sophie J Hopkin, Jenefa Begum, Silke Heising, Daniela Nasteska, Mussarat Wahid, G Ed Rainger, David J Hodson, Asif J Iqbal, Myriam Chimen & Helen M McGettrick. (2023) PEPITEM modulates leukocyte trafficking to reduce obesity-induced inflammation. Clinical and Experimental Immunology 212:1, pages 1-10.
Crossref
Crossref
Rosalind Walmsley & Priya Sumithran. (2023) Current and emerging medications for the management of obesity in adults. Medical Journal of Australia 218:6, pages 276-283.
Crossref
Crossref
Rishi Jobanputra, Jack A. Sargeant, Abdullah Almaqhawi, Ehtasham Ahmad, Franciskos Arsenyadis, David R. Webb, Louisa Y. Herring, Kamlesh Khunti, Melanie J. Davies & Thomas Yates. (2023) The effects of weight‐lowering pharmacotherapies on physical activity, function and fitness: A systematic review and meta‐analysis of randomized controlled trials. Obesity Reviews 24:4.
Crossref
Crossref
Arvid Jungnik, Jorge Arrubla Martinez, Leona Plum‐Mörschel, Christoph Kapitza, Daniela Lamers, Claus Thamer, Corinna Schölch, Michael Desch & Anita M. Hennige. (2023)
Phase I studies of the safety, tolerability, pharmacokinetics and pharmacodynamics of the dual glucagon receptor/glucagon‐like peptide‐1 receptor agonist
BI
456906
. Diabetes, Obesity and Metabolism 25:4, pages 1011-1023.
Crossref
Crossref
Ramin Abdi Dezfouli, Ali Hosseinpour, Mostafa Qorbani & Elnaz Daneshzad. (2023) The efficacy of topical aminophylline in local fat reduction: A systematic review. Frontiers in Endocrinology 14.
Crossref
Crossref
Marco Antonio Zappa, Angelo Iossa, Luca Busetto, Sonja Chiappetta, Francesco Greco, Marcello Lucchese, Fausta Micanti, Geltrude Mingrone, Giuseppe Navarra, Marco Raffaelli, Settimio Fabrizio Altorio, Luigi Angrisani, Claudio Arcudi, Fabrizio Bellini, Paolo Bernante, Rossana Berta, Esmeralda Capristo, Maria Grazia Carbonelli, Giovanni Casella, James Mariolo Casella, Lidia Castagneto Gissey, Maria Rosaria Cerbone, Franco Ciampaglia, Luigi Ciccoritti, Alessandro Contine, Giuseppe Currò, Rosella D’Alessio, Massimiliano De Palma, Daniela Delle Piane, Nino Di Benedetto, Nicola Di Lorenzo, Giovanni Fantola, Rahimi Farnaz, Mirto Foletto, Pietro Forestieri, Lucia Frittitta, Elisa Galfrascoli, Paolo Gentileschi, Cristiano Giardiello, Piero Giustacchini, Maria Paola Giusti, Ilenia Grandone, Caterina Guidone, Amerigo Iaconelli, Erminia Lembo, Silvana Leanza, Erminia Lembo, Giovanni Lezoche, Cesare Lunardi, Gennaro Martines, Bernardo Marzano, Emanuela Paone, Francesco Saverio Papadia, Federico Perrone, Luigi Piazza, Vincenzo Pilone, Pietro Pizzi, Mark Rice, Andrea Rizzi, Ferruccio Santini, Giuliano Sarro, Angelo Schettino, Nicola Tartaglia, Mauro Toppino, Antonella Usai & Maurizio De Luca. (2023) SICOB-endorsed national Delphi consensus on obesity treatment optimization: focus on diagnosis, pre-operative management, and weight regain/insufficient weight loss approach. Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity 28:1.
Crossref
Crossref
Jolijn Van Cauwenberghe, Christophe De Block, Dirk Vanderschueren & Leen Antonio. (2022) Effects of treatment for diabetes mellitus on testosterone concentrations: A systematic review. Andrology 11:2, pages 225-233.
Crossref
Crossref
Inarah Fajriaty, Hariyanto Ih, Irda Fidrianny, Neng Fisheri Kurniati, Muhammad Andre Reynaldi, I Ketut Adnyana, Rommy Rommy, Fransiska Kurniawan & Daryono Hadi Tjahjono. (2023) In Vivo Pharmacodynamics of Calophyllum soulattri as Antiobesity with In Silico Molecular Docking and ADME/Pharmacokinetic Prediction Studies. Pharmaceuticals 16:2, pages 191.
Crossref
Crossref
Young Kyoung Han, Eun Ju Jeong, Yerang Seo, In Young Lee, Suim Choi, Hyewon Lee, Choonggu Kim, Taiyoun Rhim & Kuen Yong Lee. (2022) Adipocytolytic Polymer Nanoparticles for Localized Fat Reduction. ACS Nano 17:1, pages 70-83.
Crossref
Crossref
Samantha Dalbosco Lins Carvalho, Daniela de Assumpção, Daisuke Hayashi, Antônio de Azevedo Barros Filho, Thaís Moreira São-João & Marília Estevam Cornélio. (2023) Sociodemographic, clinical, and dietary characteristics of overweight adults: a secondary analysis of a population study. Revista de Nutrição 36.
Crossref
Crossref
Natasha Chidekel Bergmann, Melanie J. Davies, Ildiko Lingvay & Filip K. Knop. (2022) Semaglutide for the treatment of overweight and obesity: A review. Diabetes, Obesity and Metabolism 25:1, pages 18-35.
Crossref
Crossref
Hubertus Himmerich & Otto Benkert. 2023. Kompendium der Psychiatrischen Pharmakotherapie. Kompendium der Psychiatrischen Pharmakotherapie
803
829
.
L. M. Kotzé-Hörstmann, D. T. Bedada, R. Johnson, L. Mabasa & H. Sadie-Van Gijsen. (2022)
The effects of a green Rooibos (
Aspalathus linearis
) extract on metabolic parameters and adipose tissue biology in rats fed different obesogenic diets
. Food & Function 13:24, pages 12648-12663.
Crossref
Crossref
Alan De la Rosa, Wissam Ghusn, Daniel Sacoto, Alejandro Campos, Lizeth Cifuentes, Fauzi Feris, Bradley Busebee, Gerardo Calderon, Andres Acosta & Maria D. Hurtado. (2022) A comparison between weight loss outcomes with anti-obesity medications before and during Covid-19 pandemic at a tertiary weight management center. Obesity Pillars 4, pages 100046.
Crossref
Crossref
Joyce Hei Tong Lau, Huda Khan, Richard Lee, Larry S. Lockshin, Anne Sharp, Jonathan Buckley & Ryan Midgley. (2022) Tackling obesity in aged-care homes: the effects of environmental cues. European Journal of Marketing 56:11, pages 3054-3077.
Crossref
Crossref
Huda Khan, Richard Lee & Zaheer Khan. (2022) The interaction of social influence and message framing on children’s food choice. European Journal of Marketing 56:11, pages 2959-2977.
Crossref
Crossref
Kemal Ağbaht & Serhan Vahit Pişkinpaşa. (2022) Serum TSH, 25(OH) D and phosphorus levels predict weight loss in individuals with diabetes/prediabetes and morbid obesity: a single-center retrospective cohort analysis. BMC Endocrine Disorders 22:1.
Crossref
Crossref
Yuxing Tai, Hongying Tian, Xiaoqian Yang, Shixing Feng, Shaotao Chen, Chongwen Zhong, Tianjiao Gao, Xiaochao Gang & Mingjun Liu. (2022) Identification of hub genes and candidate herbal treatment in obesity through integrated bioinformatic analysis and reverse network pharmacology. Scientific Reports 12:1.
Crossref
Crossref
Ching Yee Chung, Angela Wei Hong Yang, Alexander Foe, Mingdi Li & George Binh Lenon. (2022) The clinical evaluation of electroacupuncture combined with mindfulness meditation for overweight and obesity: study protocol for a randomized sham-controlled clinical trial. Trials 23:1.
Crossref
Crossref
Kaifeng Chen, Ping Luo, Shaihong Zhu, Yaqi Lin, Nan Yang, Shuqi Huang, Qin Ding, Liyong Zhu & Qi Pei. (2022) Effect of Laparoscopic Sleeve Gastrectomy on the Pharmacokinetics of Oral Omeprazole Using a Population Approach. Pharmaceutics 14:10, pages 1986.
Crossref
Crossref
Kenn Lee, Seri Abraham & Robert Cleaver. (2022) A systematic review of licensed weight-loss medications in treating antipsychotic-induced weight gain and obesity in schizophrenia and psychosis. General Hospital Psychiatry 78, pages 58-67.
Crossref
Crossref
Young Gyu Cho, Yun Jun Yang, Yeong Sook Yoon, Eon Sook Lee, Jun Hyung Lee, Yulah Jeong & Chang Ho Kang. (2022) Effect of MED-02 Containing Two Probiotic Strains, Limosilactobacillus fermentum MG4231 and MG4244, on Body Fat Reduction in Overweight or Obese Subjects: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study. Nutrients 14:17, pages 3583.
Crossref
Crossref
Jin Jin, Jiani Wang, Ruyue Cheng, Yan Ren, Zhonghua Miao, Yating Luo, Qingqing Zhou, Yigui Xue, Xi Shen, Fang He & Haoming Tian. (2022) Orlistat and ezetimibe could differently alleviate the high-fat diet-induced obesity phenotype by modulating the gut microbiota. Frontiers in Microbiology 13.
Crossref
Crossref
Richard M. O'Connor & Paul J. Kenny. (2022) Utility of ‘substance use disorder’ as a heuristic for understanding overeating and obesity. Progress in Neuro-Psychopharmacology and Biological Psychiatry 118, pages 110580.
Crossref
Crossref
Mahanjit Konwar, Debdipta Bose, Sanjeet Kumar Jaiswal, Mitesh kumar Maurya & Renju Ravi. (2022) Efficacy and Safety of Liraglutide 3.0 mg in Patients with Overweight and Obese with or without Diabetes: A Systematic Review and Meta-Analysis. International Journal of Clinical Practice 2022, pages 1-14.
Crossref
Crossref
Laura A. Barrett, Aiwen Xing, Julia Sheffler, Elizabeth Steidley, Terrence J. Adam, Rui Zhang & Zhe He. (2022) Assessing the use of prescription drugs and dietary supplements in obese respondents in the National Health and Nutrition Examination Survey. PLOS ONE 17:6, pages e0269241.
Crossref
Crossref
Min Min, Xiangyan Ruan & Alfred O. Mueck. (2022) Advanced therapy of overweight or obese polycystic ovary syndrome: a prospective study. Global Health Journal 6:2, pages 75-79.
Crossref
Crossref
Kazushi Uneda, Yuki Kawai, Takayuki Yamada, Akira Kaneko, Ryuji Saito, Lin Chen, Tomoaki Ishigami, Takao Namiki & Tadamichi Mitsuma. (2022) Japanese traditional Kampo medicine bofutsushosan improves body mass index in participants with obesity: A systematic review and meta-analysis. PLOS ONE 17:4, pages e0266917.
Crossref
Crossref
Vikram Kumar, Desh Deepak Singh, Sudarshan Singh Lakhawat, Nusrath Yasmeen, Aishwarya Pandey & Rajeev K. Singla. (2022) Biogenic Phytochemicals Modulating Obesity: From Molecular Mechanism to Preventive and Therapeutic Approaches. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-20.
Crossref
Crossref
Jasna Klen & Vita Dolžan. (2022) Glucagon-like Peptide-1 Receptor Agonists in the Management of Type 2 Diabetes Mellitus and Obesity: The Impact of Pharmacological Properties and Genetic Factors. International Journal of Molecular Sciences 23:7, pages 3451.
Crossref
Crossref
Stefano Del Prato, Baptist Gallwitz, Jens Juul Holst & Juris J. Meier. (2021) The incretin/glucagon system as a target for pharmacotherapy of obesity. Obesity Reviews 23:2.
Crossref
Crossref
Jiawen Dong, Sophie Jones, Yasmin Tabbakh & Tricia M-M. Tan. (2022) The clinical outcomes, appetite and metabolic effects of sleeve gastrectomy and Roux-en-Y gastric bypass: A comparative review. Current Opinion in Endocrine and Metabolic Research 22, pages 100315.
Crossref
Crossref
Stella Stabouli, Nonnie Polderman, Christina L. Nelms, Fabio Paglialonga, Michiel J. S. Oosterveld, Larry A. Greenbaum, Bradley A. Warady, Caroline Anderson, Dieter Haffner, An Desloovere, Leila Qizalbash, José Renken-Terhaerdt, Jetta Tuokkola, Johan Vande Walle, Vanessa Shaw, Mark Mitsnefes & Rukshana Shroff. (2021) Assessment and management of obesity and metabolic syndrome in children with CKD stages 2–5 on dialysis and after kidney transplantation—clinical practice recommendations from the Pediatric Renal Nutrition Taskforce. Pediatric Nephrology 37:1, pages 1-20.
Crossref
Crossref
Wanzi Jiang, Shushu Huang, Shuai Ma, Yingyun Gong, Zhenzhen Fu, Li Zhou, Wen Hu, Guofang Mao, Zhimin Ma, Ling Yang, Guangfeng Tang, Xiaofang Sun, Ping Zhang, Jianling Bai, Lei Chen, Bimin Shi, Xinhua Ye & Hongwen Zhou. (2021) Effectiveness of companion-intensive multi-aspect weight management in Chinese adults with obesity: a 6-month multicenter randomized clinical trial. Nutrition & Metabolism 18:1.
Crossref
Crossref
James D. Haddad & Shawn L. Shah. (2022) Medical Management of Obesity as it Affects Reflux. Foregut: The Journal of the American Foregut Society 1:4, pages 328-335.
Crossref
Crossref
André J. Scheen. (2021) Médicaments anti-obésité : leçons des échecs pour l’avenir. Médecine des Maladies Métaboliques 15:8, pages 734-743.
Crossref
Crossref
Zhiguo Li, Xuexun Fang & Dahai Yu. (2021) Transdermal Drug Delivery Systems and Their Use in Obesity Treatment. International Journal of Molecular Sciences 22:23, pages 12754.
Crossref
Crossref
Nick Finer. (2021) Future directions in obesity pharmacotherapy. European Journal of Internal Medicine 93, pages 13-20.
Crossref
Crossref
Erind Gjermeni, Anna S. Kirstein, Florentien Kolbig, Michael Kirchhof, Linnaeus Bundalian, Julius L. Katzmann, Ulrich Laufs, Matthias Blüher, Antje Garten & Diana Le Duc. (2021) Obesity–An Update on the Basic Pathophysiology and Review of Recent Therapeutic Advances. Biomolecules 11:10, pages 1426.
Crossref
Crossref
Jerome Boursier, Rodolphe Anty, Claire Carette, Bertrand Cariou, Laurent Castera, Cyrielle Caussy, Helene Fontaine, Armand Garioud, Pierre Gourdy, Bruno Guerci, Maeva Guillaume, Niasha Michot, Anne Minello, Dann J Ouizeman, Lawrence Serfaty, Fabrice Bonnet, Bruno Vergès & Jean-Michel Petit. (2021) Management of diabetes mellitus in patients with cirrhosis: An overview and joint statement. Diabetes & Metabolism 47:5, pages 101272.
Crossref
Crossref
Jan Miroslav Hartinger. (2021) Novel drugs in pharmacotherapy of obesity. Praktické lékárenství 17:2, pages 74-80.
Crossref
Crossref
Andrea Cignarella, Luca Busetto & Roberto Vettor. (2021) Pharmacotherapy of obesity: An update. Pharmacological Research 169, pages 105649.
Crossref
Crossref
Anna M. FORMENTI. (2021) Obesity: towards a personalized management of a disease with severe clinical implication. Minerva Endocrinology 46:2.
Crossref
Crossref
Xiang‐Guo Lei, Jia‐Qi Ruan, Chen Lai, Ziyi Sun & Xi Yang. (2021) Efficacy and Safety of Phentermine/Topiramate in Adults with Overweight or Obesity: A Systematic Review and Meta‐Analysis. Obesity 29:6, pages 985-994.
Crossref
Crossref
Jie Mei, Rong Yang, Qiaohong Yang, Wencheng Wan & Xiaoyong Wei. (2021) Proteomic screening identifies the direct targets of chrysin anti-lipid depot in adipocytes. Journal of Ethnopharmacology 267, pages 113361.
Crossref
Crossref
Ann A. Verhaegen & Luc F. Van Gaal. (2021) Drugs Affecting Body Weight, Body Fat Distribution, and Metabolic Function—Mechanisms and Possible Therapeutic or Preventive Measures: an Update. Current Obesity Reports 10:1, pages 1-13.
Crossref
Crossref
Pravin Shende & Roma Narvenker. (2021) Herbal nanotherapy: A new paradigm over conventional obesity treatment. Journal of Drug Delivery Science and Technology 61, pages 102291.
Crossref
Crossref
Habeeb Alhabeeb, Ali AlFaiz, Emad Kutbi, Dayel AlShahrani, Abdullah Alsuhail, Saleh AlRajhi, Nemer Alotaibi, Khalid Alotaibi, Saad AlAmri, Saleh Alghamdi & Naji AlJohani. (2021) Gut Hormones in Health and Obesity: The Upcoming Role of Short Chain Fatty Acids. Nutrients 13:2, pages 481.
Crossref
Crossref
Steven B. Heymsfield, Laura A. Coleman, Ram Miller, Daniel S. Rooks, Didier Laurent, Olivier Petricoul, Jens Praestgaard, Therese Swan, Thomas Wade, Robert G. Perry, Bret H. Goodpaster & Ronenn Roubenoff. (2021) Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity. JAMA Network Open 4:1, pages e2033457.
Crossref
Crossref
Young Jin Tak & Sang Yeoup Lee. (2021) Anti-Obesity Drugs: Long-Term Efficacy and Safety: An Updated Review. The World Journal of Men's Health 39:2, pages 208.
Crossref
Crossref
Hubertus Himmerich, Carol Kan, Katie Au & Janet Treasure. (2021) Pharmacological treatment of eating disorders, comorbid mental health problems, malnutrition and physical health consequences. Pharmacology & Therapeutics 217, pages 107667.
Crossref
Crossref
Sachin Kumar, Tapan Behl, Monika Sachdeva, Aayush Sehgal, Shilpa Kumari, Arun Kumar, Gagandeep Kaur, Harlokesh Narayan Yadav & Simona Bungau. (2021) Implicating the effect of ketogenic diet as a preventive measure to obesity and diabetes mellitus. Life Sciences 264, pages 118661.
Crossref
Crossref
Hubertus Himmerich & Otto Benkert. 2021. Kompendium der Psychiatrischen Pharmakotherapie. Kompendium der Psychiatrischen Pharmakotherapie
739
758
.
Rüdiger Landgraf. (2020) Prävention, Remission oder Verzögerung der Typ-2-Diabetes-Manifestation – Teil 1. Diabetologie und Stoffwechsel 15:05, pages 377-391.
Crossref
Crossref
Marcus May & Stefan Engeli. (2020) Gewichtsänderung als unerwünschte Arzneimittelwirkung. Adipositas - Ursachen, Folgeerkrankungen, Therapie 14:03, pages 133-139.
Crossref
Crossref
Hellas Cena, Luca Chiovato & Rossella E Nappi. (2020) Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists. The Journal of Clinical Endocrinology & Metabolism 105:8, pages e2695-e2709.
Crossref
Crossref
Hana R. Bajes, Ihab Almasri & Yasser Bustanji. (2020) Plant Products and Their Inhibitory Activity Against Pancreatic Lipase. Revista Brasileira de Farmacognosia 30:3, pages 321-330.
Crossref
Crossref
David M. Williams, Asif Nawaz & Marc Evans. (2020) Drug Therapy in Obesity: A Review of Current and Emerging Treatments. Diabetes Therapy 11:6, pages 1199-1216.
Crossref
Crossref